Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0000737 (
abdominal pain
)
31,184
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
77 hospitalized patients with chronic unspecific abdominal complaints, in whom any other organic disease had been previously excluded, were investigated for
lactose
malabsorption; they were subdivided into two groups: 46 patients complaining primarily of colicky
abdominal pain
and/or intermittent diarrhoea (group 1) and 31 patients presenting with dyspepsia as the predominant symptom (group 2). To establish the exact prevalence of isolated lactase deficiency in the healthy adult population served by our hospital, 40 Italian adult healthy subjects were also studied. The prevalence of
lactose
malabsorption was significantly higher (p less than 0.005) in patients of the 1st group than in patients of the 2nd group, and in the healthy adult population seen at our hospital (74% vs 35.5% and 37.5%, respectively). Furthermore a high prevalence of lactose intolerance, determined by means of a three-week diet trial (
lactose
free-diet versus normal diet), was documented among
lactose
malabsorbers of the 1st group. We concluded therefore that lactose intolerance is a factor in some Italian adult patients who suffer from long-standing aspecific abdominal discomfort, and it should be always considered in these patients, especially when colicky
abdominal pain
and diarrhoea are present, before the diagnosis of irritable bowel syndrome is made.
...
PMID:Lactose intolerance in adults with chronic unspecific abdominal complaints. 667 46
The aim of this study was to determine the incidence of
lactose
malabsorption in healthy, adult Australian Aborigines. Malabsorption of
lactose
was measured in 45 full blooded Aboriginal subjects and 37 nonAboriginal multiracial controls using the breath hydrogen method. 84% of the Aboriginal subjects were found to be
lactose
malabsorbers and 64% developed
abdominal pain
or diarrhea. In the control subjects, 20% were found to be
lactose
malabsorbers and all of these developed symptoms of diarrhea. The results provide strong evidence that Australian Aborigines, in common with most human adults, are lactase deficient.
...
PMID:Lactose malabsorption in Australian Aborigines. 682 86
Lactose breath hydrogen tests were given to 70 children and adolescents with chronic ulcerative colitis and Crohn's disease in order to determine the prevalence of
lactose
malabsorption in childhood inflammatory bowel disease. Twenty-nine percent of these patients demonstrated
lactose
malabsorption; the majority of these children (70%) experienced gastro-intestinal symptoms during the test. The prevalence was not significantly different whether the diagnosis was ulcerative colitis or Crohn's disease. With the exception of those with diffuse small bowel disease, the location of intestinal involvement with Crohn's disease and the severity of clinical symptoms did not affect
lactose
malabsorption. Lactose malabsorption was not more frequent in patients with inflammatory bowel disease than in a group of children with recurrent
abdominal pain
and normal gastrointestinal x-rays, although significant differences in the prevalence of
lactose
malabsorption were observed in relation to ethnic background. Milk incubated with commercially available yeast lactase (lactAid, Surgarlo Co., Atlantic City, N.J.) for greater than 24 h prevented an increase in breath hydrogen when administered to 6 patients previously shown to have
lactose
malabsorption.
...
PMID:Lactose malabsorption in children and adolescents with inflammatory bowel disease. 689 2
In order to evaluate the role of
lactose
malabsorption in children with recurrent
abdominal pain
, we performed a prospective controlled double-blinded study in 40 children with RAP of at least three months' duration. Children were studied for
lactose
malabsorption by breath hydrogen determinations after ingestion of
lactose
(2 gm/kg of body weight; maximum 50 gm). Lactose malabsorbers were retested with 12.5 gm
lactose
;
lactose
absorbers were retested with
lactose
for ability to produce hydrogen. All children underwent a dietary trial which included two
lactose
elimination periods. Although 12 children (30%) were
lactose
malabsorbers, only three malabsorbed part of the smaller, more physiologic,
lactose
load. Improvement rates of
lactose
malabsorbers and absorbers during
lactose
elimination were not significantly different as judged by their physicians and as determined by a 50% or more decrease in pain frequency. These results suggest that
lactose
malabsorption is of little importance in children with RAP.
...
PMID:Lactose malabsorption in recurrent abdominal pain of childhood. 705 18
The association of lactase deficiency with recurrent
abdominal pain
was investigated. One hundred three white children between the ages of 6 to 14 years with recurrent
abdominal pain
were evaluated. Sixty-nine underwent
lactose
tolerance tests and 26 had intestinal biopsies with lactase determinations; 21 of 69 (30.4%) had abnormal
lactose
tolerance tests and eight of 26 (31%) were lactase deficient. However, 16 of 61 (26.4%) control subjects matched for age and ethnic background exhibited lactase deficiency. Thus, a similar prevalence of lactase deficiency was found in the control and the recurrent
abdominal pain
groups. Thirty-eight patients with recurrent
abdominal pain
completed three successive six-week diet trials conducted in a double-blind fashion. An increase above base line value in pain frequency was seen in ten of 21 (48%)
lactose
malabsorbers and four of 17 (24%)
lactose
absorbers. After a 12-month milk elimination diet, six of 15 (40%) malabsorbers and five of 13 (38%) absorbers had elimination of their pain. This result compared with improvement occurring in five of 12 (42%) absorbers with recurrent
abdominal pain
who received a regular diet for one year and suggests that the elimination of
lactose
will not affect the overall frequency of improvement in recurrent
abdominal pain
. In addition, the recovery rate from recurrent
abdominal pain
is similar in both
lactose
absorbers and nonabsorbers independent of dietary restrictions.
...
PMID:Recurrent abdominal pain and lactose absorption in children. 719 4
After a review of causes and symptoms of sugar malabsorption and the usual diagnostic methods, the application is described of a recently developed procedure with high specificity and sensitivity: the hydrogen breath test. Examination of a large number of children shows that its sensitivity is higher than that of the procedures used so far, that
lactose
malabsorption is present in over 30% of the children with recurrent
abdominal pain
and/or diarrhoea; that in contrast to the prevailing opinion, malabsorption of sucrose in children is rare.
...
PMID:[Diagnosis of carbohydrate malabsorption]. 726 53
To evaluate the role of the
lactose
breath hydrogen test for the detection of
lactose
malabsorption in children with chronic nonspecific abdominal complaints, breath hydrogen excretion was measured in 131 children with recurrent
abdominal pain
(n = 75) or chronic nonspecific diarrhea (n = 56) following a
lactose
load (2 gm/kg; maximum 50 gm). The data were compared to those obtained from
lactose
tolerance tests (n = 113) and symptom response following a
lactose
load (n = 109) performed simultaneously with the
lactose
breath hydrogen test, and with results from small bowel biopsies obtained in 31 children to determine dissacharidase activity and mucosal histology. The results indicate that an increase in breath hydrogen of greater than 10 ppm above base line values (delta ppm) by 120 minutes ("early increase" response) completely discriminates between biopsy-proven isolated lactase-insufficient and lactase-sufficient children. A similar increase after 120 minutes ("late increase" response) is consistent both with normal mucosal function and partial lactase insufficiency due to mucosal injury. Breath hydrogen responses predicted assayed lactase activity in all patients with isolated lactase insufficiency, but were "falsely negative" in four of ten children whose lactase insufficiency was secondary to mucosal injury. In both clinical groups,
lactose
malabsorbers report significantly more symptoms than absorbers (P less than .001), but neither symptom reports nor tolerance tests are accurate methods for distinguishing
lactose
malabsorbers from absorbers. Although the
lactose
breath hydrogen test provides objective documentation of
lactose
malabsorption, it is equally predictive of assayed lactase activity in all clinical groups.
...
PMID:Mucosal function and breath hydrogen excretion: comparative studies in the clinical evaluation of children with nonspecific abdominal complaints. 732 85
Abdominal pain
and diarrhea are frequent side effects of chronic colchicine therapy. Drug-induced
lactose
deficiency has been demonstrated in the experimental animal. Lactose malabsorption was assessed by the
lactose
breath test in 23 patients with familial Mediterranean fever (FMF) receiving colchicine for 0.25-15 years (mean 3.16). Twenty FMF patients not receiving colchicine and 38 non-FMF
lactose
malabsorbers served as controls. Patients receiving colchicine had a significantly higher percentage of
lactose
malabsorption (20/23, 87%) versus nontreated FMF patients (13/20, 65%; P < 0.05). Lactose intolerance was also more prevalent in colchicine-treated patients (17/23, 74%) versus nontreated FMF (5/20, 25%; P < 0.0005) and control
lactose
malabsorbers (16/38, 42%; P < 0.01). Of the 12 patients investigated before and 3 months after colchicine administration, 7 showed induction or aggravation of
lactose
malabsorption. The
lactose
-free diet resulted in partial improvement of symptoms. Colchicine induces significant
lactose
malabsorption in FMF patients and this is partially responsible for the gastrointestinal side effects of the drug.
...
PMID:Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever. 759 85
Our objectives were to evaluate children with recurrent
abdominal pain
for
lactose
maldigestion and to assess factors which might predict
lactose
absorption status. One hundred thirty-seven children were referred for specialty evaluation of recurrent
abdominal pain
of at least three months' duration. Study subjects were evaluated by history and physical examination, dietary interviews, hematologic and biochemical laboratory testing, stool parasite examination, and radiologic or endoscopic structural examinations, as indicated. Lactose hydrogen breath testing was performed after challenge with 1 g/kg
lactose
10% aqueous solution). There were 53 males and 84 females, whose ages ranged from 6 to 18 years (9.64 +/- 2.9; mean +/- SD) Lactose maldigestion was detected in 33/137 patients (24%). The prevalence of
abdominal pain
, bloating, gas, flatulence, diarrhea, and constipation was similar in children with or without
lactose
maldigestion. The perception of symptoms related to the ingestion of dairy products was similar in both groups. No other clinical parameter predicted
lactose
maldigestion. However, children with
lactose
maldigestion had overall clinical improvement with a
lactose
-restricted diet. Clinical evaluation alone cannot adequately predict the presence of
lactose
maldigestion in children. Formal evaluation for
lactose
maldigestion using breath hydrogen testing methods should be considered in children with recurrent
abdominal pain
.
...
PMID:Lactose maldigestion and recurrent abdominal pain in children. 762 74
We sought to prospectively characterize and compare the symptoms of children > or = 5 years of age with recurrent
abdominal pain
to previously established criteria for irritable bowel syndrome (IBS) in adults. For all eligible subjects, a detailed questionnaire concerning characteristics of
abdominal pain
and defecatory pattern was completed at presentation. In addition, a battery of screening tests was performed and additional evaluation was done at the discretion of their physician. In all, 227 subjects fulfilled the entrance criteria, but 56 were subsequently excluded because of diagnoses of inflammatory bowel disease (nine cases),
lactose
malabsorption (46 cases), or celiac disease (one case). Of the remaining 171 patients, 117 had IBS symptoms. In the IBS subjects, lower abdominal discomfort (p < 0.001), cramping pain (p < 0.0009), and increased flatus (p < 0.0003) were more common, whereas dyspeptic symptoms such as epigastric discomfort (p < 0.003), pain radiating to the chest (p < 0.009), and regurgitation (p < 0.02) were more common in the non-IBS subjects. Our study not only confirms the clinical heterogeneity of children with recurrent
abdominal pain
but also concomitantly demonstrates that most children with this disorder have symptoms that fulfill the standardized criteria for IBS in adults. The identification of subgroups of children with recurrent
abdominal pain
can provide a framework for the diagnosis of functional bowel disease as well as establish the need for invasive and expensive tests.
...
PMID:Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. 913 90
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>